Semaglutide A GLP-1 receptor agonist that improves satiety, regulates blood sugar, and supports significant body weight reduction
In addition to regulating blood sugar and lowering body weight in non-diabetic obese patients, tirzepatide can also lower liver fat and improve kidney outcomes (Rosenstock et al., 2025)
Vishesh Bharucha +2 more Table of Contents In todays busy life, many people are looking for easy or no effort ways for weight reduction
While these medicines are generally safe, many people have reported some side effects 1 , especially during the early stages of treatment 2
During T2D development, chronic overnutrition interferes with insulin signaling leading to decreases in insulin sensitivity
Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management